NCT00671229View on ClinicalTrials.gov

Nitric Oxide, LPS and the Pathogenesis of Asthma Phase 1

CompletedOBSERVATIONAL
Enrollment

420

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
HealthyAsthma
Trial Locations (1)

27710

Duke University Medical Center, Durham

All Listed Sponsors
collaborator

Sandler Program for Asthma Research

OTHER

lead

National Institute of Environmental Health Sciences (NIEHS)

NIH

NCT00671229 - Nitric Oxide, LPS and the Pathogenesis of Asthma Phase 1 | Biotech Hunter | Biotech Hunter